| Literature DB >> 28264698 |
Jean P Dzoyem1,2, Raduis Melong3,4, Armelle T Tsamo3, Alembert T Tchinda5, Deccaux G W F Kapche4, Bonaventure T Ngadjui3, Lyndy J McGaw6, Jacobus N Eloff6.
Abstract
BACKGROUND: Entada abyssinica is a plant traditionally used against gastrointestinal bacterial infections. Eight compounds including three flavonoids, three terpenoids, a monoglyceride and a phenolic compound isolated from E. abyssinica were investigated for their cytotoxicity, antibacterial and antioxidant activity.Entities:
Keywords: Antibacterial; Cytotoxicity; Entada abyssinica; Free radical scavenging
Mesh:
Substances:
Year: 2017 PMID: 28264698 PMCID: PMC5339975 DOI: 10.1186/s13104-017-2441-z
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Chemical structures of ursolic acid (1), quercetin-3-O-α-l-rhamnoside or quercitrin (2), quercetin 3-O-β-d-glucosyl (1→4)-α-l-rhamnoside (3), (8S)-kolavic acid 15-methyl ester (4), 13,14,15,16-tetranor-3-clerodene-12,18-dioic acid (5), methyl gallate (6), entadanin (7), bis-[(S)-(2,3-dihydroxypropyl)] hexacosanedioate (8)
Antibacterial activity of eight compounds isolated from Entada abyssinica (MIC in µg/mL)
| Compounds | MIC (µg/mL) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| 12.5 | 6.25 | 100 | – | – | – |
|
| 12.5 | 3.12 | 50 | 25 | 50 | |
|
| 25 | 50 | 25 | 50 | 50 | 25 |
|
| 25 | 25 | 100 | – | – | – |
|
| – | – | – | – | – | – |
|
| 50 | 50 | 25 | – | – | – |
|
| 12.5 | 25 | 1.56 | 25 | – | 12.5 |
|
| – | – | – | – | – | – |
| Gentamicin | 0.5 | 0.5 | 2 | 0.25 | 0.25 | 1 |
– 100 µg/mL. Sa Staphylococcus aureus, Ef Enterococcus faecalis, Bc Bacillus cereus, Ec Escherichia coli, Pa Pseudomonas aeruginosa, St Salmonella typhimurium
Antioxidant activity of eight compounds isolated from Entada abyssinica
| Compounds | DPPH (IC50, µg/mL) | ABTS (IC50, µg/mL) | FRAP (µmol FeSO4/g) |
|---|---|---|---|
|
| 2.87 ± 1.19a | 7.04 ± 1.29a | 1.43 ± 0.80a |
|
| 0.9 ± 0.06b | 3.53 ± 0.39b | 76.01 ± 1.10b |
|
| 2.08 ± 0.19a | 17.04 ± 0.26c | 75.34 ± 1.06b |
|
| – | – | 1.93 ± 0.14a |
|
| – | – | 5.09 ± 0.40c |
|
| 0.48 ± 0.02c | 2.53 ± 0.49d | 103.98 ± 13.70d |
|
| 1.12 ± 0.10c,d | 4.13 ± 0.10e | 72.41 ± 2.02b,e |
|
| – | – | 22.98 ± 4.29f |
| Trolox | 8.71 ± 2.03e | 10.38 ± 2.4a,f | nd |
| Ascorbic acid | 3.44 ± 1.9a,f | 4.15 ± 1.21d,e | nd |
Data represent the mean ± SD of three independent experiments; values with different letters are significantly different at p < 0.05
nd not determined, – 100 µg/mL
Cytotoxicity (LC50 in µg/mL) of eight compounds isolated from Entada abyssinica and their selectivity index (SI) values against normal and cancer cell lines
| Compounds | Vero LC50 | THP-1 | RAW 264.7 | ||
|---|---|---|---|---|---|
| LC50 | SI | LC50 | SI | ||
|
| 22.42 ± 2.48a | 9.62 ± 0.59a | 7.32 | 4.56 ± 0.020a | 15.44 |
|
| 44.83 ± 2.83b | – | nd | 16.44 ± 0.20b | 4.28 |
|
| 53.76 ± 2.05c | – | nd | 41.90 ± 0.43c | 1.68 |
|
| 47.46 ± 0.63b,d | 49.78 ± 3.03b | 1.41 | 52.30 ± 1.30d | 1.35 |
|
| 41.91 ± 1.85b,e | 21.81 ± 1.11c | 3.23 | 16.10 ± 1.00b | 4.37 |
|
| 30.58 ± 3.09f | 75.00 ± 1.68d | 0.94 | 36.92 ± 1.27e | 1.91 |
|
| 55.65 ± 0.30c | 84.28 ± 3.30e | 0.84 | 19.12 ± 0.25f | 3.68 |
|
| 80.50 ± 4.83g | 65.00 ± 6.88d,f | 1.08 | 86.55 ± 4.61g | 0.81 |
| Doxorubicin | 9.35 ± 0.66h | – | nd | 0.5 ± 0.00h | nd |
| Puromycin | 5.32 ± 0.90i | 0.4 ± 0.02g | 176.03 | 1.15 ± 0.17i | 61.23 |
Data represent the mean ± SD of three independent experiments; values with different letters are significantly different at p < 0.05
nd not determined, – 100 µg/mL